L.V.G. Pharma SRL
L.V.G. Pharma reported total assets of €1.06m at the end of the 2025 financial year (annual accounts filed with the NBB on 27 May 2026).
By total assets for 2025, L.V.G. Pharma ranks in the top half of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of L.V.G. Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +9 % Total assets +1 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
L.V.G. Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 May 2026
- Year ended 31 Dec 2024filed on 18 Jul 2025
- Year ended 31 Dec 2023filed on 10 Jun 2024
- Year ended 31 Dec 2022filed on 09 Jun 2023
- Year ended 31 Dec 2021filed on 30 May 2022
L.V.G. Pharma's financial analysis
- Solvency75.6%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of L.V.G. Pharma
L.V.G. Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0861.341.984
- VAT number
- BE0861341984
- Peppol
- Registered · 0208:0861341984 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Oct 2003
- Registered office
- 2870 Puurs-Sint-Amands
- Latest accounts
- 2025 · filed on 27 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
L.V.G. Pharma (SRL) has been based in Puurs-Sint-Amands since 2003, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 99,130 € and equity of 799,333 €; its revenue is not published. Its solvency stands at 75.6%, above the median of its sector (44.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to L.V.G. Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Verhaeghe Pharma Retail sale of pharmaceutical products Izegem · balance sheet €1.05m
- Pharmadvance Retail sale of pharmaceutical products Chièvres · balance sheet €1.07m
- Van Geem Retail sale of pharmaceutical products Antwerp · balance sheet €1.08m
- Capavita Retail sale of pharmaceutical products Schoten · balance sheet €1.09m
- Apoteek Mommaert Retail sale of pharmaceutical products Beersel · balance sheet €1.09m
- Novaka Pharma Retail sale of pharmaceutical products Nivelles · balance sheet €1.10m
- PharmaLEDA Retail sale of pharmaceutical products Ixelles · balance sheet €1.01m
Frequently asked questions about L.V.G. Pharma
What is the revenue of L.V.G. Pharma?
L.V.G. Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of L.V.G. Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0861341984 for L.V.G. Pharma, if the company is VAT-registered. Its company number (CBE) is 0861.341.984.
Where is the registered office of L.V.G. Pharma?
According to the CBE register, the registered office of L.V.G. Pharma is in 2870 Puurs-Sint-Amands.
What is the equity of L.V.G. Pharma?
At the close of the 2025 financial year, the equity of L.V.G. Pharma amounts to 799,333 €, a solvency of 75.6% of total assets.
Who manages L.V.G. Pharma?
The register lists 1 active mandates at L.V.G. Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is L.V.G. Pharma within its sector?
By total assets for 2025, L.V.G. Pharma ranks in the top half of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year.
The full file of L.V.G. Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →